MedTech News

Medtronic receives Type 2 label expansion for MiniMed 780G in Europe
The CE mark also allows Medtronic’s automated insulin delivery system to be used during pregnancy and by children as young as 2.

Adhesive inspired by hitchhiking sucker fish sticks to soft surfaces underwater
Inspired by a hitchhiking fish that uses a specialized suction organ to latch onto sharks and other marine animals, researchers from MIT and other institutions have designed a mechanical adhesive device that can attach to soft surfaces underwater or in extreme conditions, and remain there for days or weeks.

BioPhotas, Inc. Launches First 5-Mode, Battery-Powered, FDA Cleared Device
TUSTIN, Calif., July 22, 2025 /PRNewswire/ — Celluma Light Therapy, the global leader in award-winning, clinically backed LED technology, announces the launch of the Celluma NOVA, the first-of-its-kind battery-powered, shape-taking LED panel with five FDA-cleared treatment modes. The Celluma NOVA treats aging skin, pain, hair restoration, body contouring, and acne — all in a single compact, rechargeable device.

Takeda Secures FDA 510(k) Clearance for HyHub™ and HyHub™ Duo Devices
New devices designed to streamline and personalize HYQVIA® administration for patients receiving subcutaneous immune globulin therapy

Autonomix Medical Secures New U.S. Patent for Advancing Nerve-Targeted, Minimally Invasive Therapies
Patent strengthens company’s IP portfolio as it expands innovative treatments for chronic pain, oncology, and other high-need conditions

New diagnostic breakthrough predicts which head and neck cancer patients can be cured with surgery alone
Researchers from the University of Turku and Turku University Hospital, Finland, led by Docent Sami Ventelä and Professor Jukka Westermarck, have developed a diagnostic tool that can revolutionize the treatment guidance of head and neck squamous cell carcinoma.

Radiation therapy overcomes immunotherapy resistance in some cancers
By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to the treatment, leading to positive outcomes for patients, according to new research by investigators at the Johns Hopkins Kimmel Cancer Center Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Netherlands Cancer Institute.

Tailored deep brain stimulation improves walking in Parkinson’s disease
For patients with Parkinson’s disease, changes in their ability to walk can be dramatic. “Parkinson’s gait,” as it is often called, can include changes in step length and asymmetry between legs. This gait dysfunction reduces a person’s mobility, increases fall risk, and significantly impacts a patient’s quality of life.